Vaccination

New malaria vaccine proves highly effective – and COVID shows how quickly it could be deployed

For the first time, a malaria vaccine has shown high efficacy in trials. Image: Pixabay/jggrz

Adrian Hill

Director of the Jenner Institute, University of Oxford

Share:
Our Impact
The Big Picture
Explore and monitor how Vaccination is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Vaccination

Have you read?
Discover

How has the Forum navigated the global response to COVID-19?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
VaccinationCOVID-19Global HealthHealth and HealthcareScience
Share:
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Measles: Why the World Health Organization has declared it an ‘imminent global threat’

Michael Head

December 13, 2022

About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2023 World Economic Forum